title: Interleukin-6 as a therapeutic target in spondylarthritis: comment on the article by Tanaka et al.
authors.forename: Daniel
authors.initials: D
authors.lastname: Wendling
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000627:therapeutic use; D006801:Humans; D025241:Spondylarthritis / Q000188:drug therapy*; D000093242:Interleukin-6 Inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000093242:Interleukin-6 Inhibitors; C502936:tocilizumab